290 related articles for article (PubMed ID: 26412064)
1. Brain Structural Effects of Psychopharmacological Treatment in Bipolar Disorder.
McDonald C
Curr Neuropharmacol; 2015; 13(4):445-57. PubMed ID: 26412064
[TBL] [Abstract][Full Text] [Related]
2. Effects of medication on neuroimaging findings in bipolar disorder: an updated review.
Hafeman DM; Chang KD; Garrett AS; Sanders EM; Phillips ML
Bipolar Disord; 2012 Jun; 14(4):375-410. PubMed ID: 22631621
[TBL] [Abstract][Full Text] [Related]
3. The structural neuroimaging of bipolar disorder.
Emsell L; McDonald C
Int Rev Psychiatry; 2009; 21(4):297-313. PubMed ID: 20374145
[TBL] [Abstract][Full Text] [Related]
4. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
Hamrin V; Pachler M
J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
[TBL] [Abstract][Full Text] [Related]
5. The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder.
Mitchell PB
Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S99-107. PubMed ID: 10622184
[TBL] [Abstract][Full Text] [Related]
6. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
Hamrin V; McDonnell MA; Moffett J; Durso S
Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
[TBL] [Abstract][Full Text] [Related]
7. Neuroimaging alterations associated with medication use in early-onset bipolar disorder: An updated review.
Valizadeh P; Cattarinussi G; Sambataro F; Brambilla P; Delvecchio G
J Affect Disord; 2023 Oct; 339():984-997. PubMed ID: 37481130
[TBL] [Abstract][Full Text] [Related]
8. Bipolar depression: management options.
Malhi GS; Mitchell PB; Salim S
CNS Drugs; 2003; 17(1):9-25. PubMed ID: 12467490
[TBL] [Abstract][Full Text] [Related]
9. The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.
Fountoulakis KN; Yatham LN; Grunze H; Vieta E; Young AH; Blier P; Tohen M; Kasper S; Moeller HJ
Int J Neuropsychopharmacol; 2020 Apr; 23(4):230-256. PubMed ID: 31802122
[TBL] [Abstract][Full Text] [Related]
10. Anterior Cingulate Cortex Glutamatergic Metabolites and Mood Stabilizers in Euthymic Bipolar I Disorder Patients: A Proton Magnetic Resonance Spectroscopy Study.
Soeiro-de-Souza MG; Otaduy MCG; Machado-Vieira R; Moreno RA; Nery FG; Leite C; Lafer B
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Dec; 3(12):985-991. PubMed ID: 29789269
[TBL] [Abstract][Full Text] [Related]
11. The effects of lithium and anticonvulsants on brain structure in bipolar disorder.
Germaná C; Kempton MJ; Sarnicola A; Christodoulou T; Haldane M; Hadjulis M; Girardi P; Tatarelli R; Frangou S
Acta Psychiatr Scand; 2010 Dec; 122(6):481-7. PubMed ID: 20560901
[TBL] [Abstract][Full Text] [Related]
12. White matter differences in euthymic bipolar I disorder: a combined magnetic resonance imaging and diffusion tensor imaging voxel-based study.
Emsell L; Langan C; Van Hecke W; Barker GJ; Leemans A; Sunaert S; McCarthy P; Nolan R; Cannon DM; McDonald C
Bipolar Disord; 2013 Jun; 15(4):365-76. PubMed ID: 23621705
[TBL] [Abstract][Full Text] [Related]
13. The association of antipsychotic medication and lithium with brain measures in patients with bipolar disorder.
Abramovic L; Boks MP; Vreeker A; Bouter DC; Kruiper C; Verkooijen S; van Bergen AH; Ophoff RA; Kahn RS; van Haren NE
Eur Neuropsychopharmacol; 2016 Nov; 26(11):1741-1751. PubMed ID: 27665062
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.
Moore GJ; Cortese BM; Glitz DA; Zajac-Benitez C; Quiroz JA; Uhde TW; Drevets WC; Manji HK
J Clin Psychiatry; 2009 Apr; 70(5):699-705. PubMed ID: 19389332
[TBL] [Abstract][Full Text] [Related]
15. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
[TBL] [Abstract][Full Text] [Related]
16. The Gut Microbiome in Bipolar Disorder and Pharmacotherapy Management.
Flowers SA; Ward KM; Clark CT
Neuropsychobiology; 2020; 79(1):43-49. PubMed ID: 31722343
[TBL] [Abstract][Full Text] [Related]
17. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
Dunner DL
J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
[TBL] [Abstract][Full Text] [Related]
18. Treatment of bipolar disorder.
Möller HJ; Nasrallah HA
J Clin Psychiatry; 2003; 64 Suppl 6():9-17; discussion 28. PubMed ID: 12720475
[TBL] [Abstract][Full Text] [Related]
19. Prepubertal bipolar disorder: available pharmacological treatment options.
Masi G
Expert Opin Pharmacother; 2005 Apr; 6(4):547-60. PubMed ID: 15934881
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
